Shared by James Harvey
(ISSUP staff) - 22 October 2021
Format
ISSUP Webinar
ISSUP Ukraine are pleased to present the Second Webinar in their Three-Part Series on 'Mental Health of Youth and Substance'. The Second Webinar will focus specifically on Mood Disorders in Children and Adolescents.
Current evidence shows that medications are underused in the treatment of alcohol use disorder, including alcohol abuse and dependence.
Although many experts in addiction believe that patients with moderate or severe alcohol-related problems should be offered medication-assisted treatment (MAT) on a routine basis, considerable resistance to the use of MAT persists.
To clarify the situation, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) analysed the evidence on the effectiveness of available...
Shared by James Harvey
(ISSUP staff) - 21 April 2020
Format
Scientific article
Published by / Citation
Nelson LF, Yocum VK, Patel KD, Qeadan F, Hsi A, Weitzen S. Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(3):e201195. doi:10.1001/jamanetworkopen.2020.1195
Abstract
Importance: The number of children with prenatal opioid exposure to medication for addiction treatment (MAT) with methadone and buprenorphine for maternal opioid use disorder is increasing, but the associations of this exposure with cognitive outcomes are not well understood.
Objective: To examine the strength and consistency of findings in the medical literature regarding the association of prenatal exposure to MAT with early childhood cognitive development, particularly when accounting for variables outside MAT exposure.
Data Sources: A search strategy obtained publications...
The Substance Abuse and Mental Health Services Administration (SAMHSA)
The success of treatment and recovery of individuals with opioid use disorder (OUD) can vary. Most often, a combination of factors adds complexities to evaluating the effectiveness of services and interventions.
Worldwide, overdose is the leading cause of avoidable death among people who inject drugs. An important area of concern for the Substance Abuse and Mental Health Services Administration (SAMHSA) is promoting policies and practices to lower the risk of overdose for persons with opioid use disorder who are, or have been, in contact with criminal justice systems.
Moeini, Mina, Abdoallah Omidi, Mojtaba Sehat, and Hamid Reza Banafshe. "The Effects of Oxytocin on Withdrawal, Craving and Stress Response in Heroin-Dependent Patients: A Randomized, Double-Blind Clinical Trial." European addiction research 25, no. 1 (2019): 41-48.
According to the World Drug Report opioids are the most harmful drug type, accounting for 70% of the adverse health impacts associated with drug use disorders worldwide. Treatment typically focusses on controlling withdrawal, preventing cravings and ultimately relapse. Maintenance treatments are used for chronic opioid-dependent patients who cannot achieve abstinence.
A recent randomised, double-blind trialhas examined the effectiveness of oxytocin, a neuropeptide that is produced by the hypothalamus, as part of the treatment of addiction. The researchers analysed the effect of oxytocin...
Shared by Jose Luis Vazquez Martinez
- 21 February 2019
Event Date
Location:
Webinar
United States
March 5th 11:00am-12:00pm
Drs. Kariisa and Roehler will provide an overview of CDC’s Enhanced State Opioid Overdose Surveillance (ESOOS) program. We will highlight the three key strategies CDC is employing to improve opioid-related...